Synaptive Medical Appoints Peter Wehrly as Ceo

TORONTO, ON (October 5, 2017) – Synaptive Medical, a leading Canadian medical device and technology company, announced today the appointment of veteran healthcare executive and current chairman of the board Peter Wehrly as chief executive officer. Cameron Piron will continue to serve as president and assume the new role of chief strategy officer.

As CEO, Peter’s primary focus will be on business operations, commercial execution, product development and execution to strategy. Cameron, as president and chief strategy officer, will focus on Synaptive’s long-term vision, strategic relationships, collaboration with employees and clients, investor relations and advanced research. Together, they will provide visionary and strategic leadership, as well as operational excellence in product development and commercialization.

Peter’s addition to the executive leadership team will enable Synaptive to grow and continue its current success. Hiring a CEO has been part of Synaptive’s long-term plan to scale and grow as a medical device and technology company. I am excited to continue to work with Peter in his new role to lead Synaptive as we continue our momentum towards executing product development milestones, achieving financial goals and ensuring we have a work environment that fosters high employee engagement
— Cameron Piron, President, Synaptive Medical

For the full press release on the company website click here